NCT07682649
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07682649
Title Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer (ESCENDO)
Acronym ESCENDO
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Rogel Cancer Center Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field